Oxidative stress and lung inflammation in airways disease

Authors
Citation
W. Macnee, Oxidative stress and lung inflammation in airways disease, EUR J PHARM, 429(1-3), 2001, pp. 195-207
Citations number
136
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
429
Issue
1-3
Year of publication
2001
Pages
195 - 207
Database
ISI
SICI code
0014-2999(20011019)429:1-3<195:OSALII>2.0.ZU;2-0
Abstract
Oxidative stress results from an oxidant/antioxidant imbalance in favour of oxidants. A large number of studies have demonstrated that increased oxida tive burden occurs in airways diseases, shown by increased marks of oxidati ve stress in the airspaces and systemically in these patients. There is now substantial evidence that oxidative stress plays an important role in the injurious and inflammatory responses in airways diseases such as asthma and chronic obstructive pulmonary disease (COPD). In addition to these proinfl ammatory mechanisms resulting from oxidative stress, protective mechanisms such as the upregulation of protective antioxidant genes also occur. At pre sent, effective antioxidant therapy that has good bioavailability and poten cy is not available. Such drugs are being developed and should in the futur e allow the hypothesis that oxidative stress is a fundamental factor in the inflammation, which occurs in these airways diseases to be tested. (C) 200 1 Elsevier Science B.V. All rights reserved.